Volatile anaesthetic effects on phospholipid binding to synaptotagmin 1, a presynaptic Ca2+ sensor

British Journal of Anaesthesia

Volumn 95, Issue 2 PAPER, 2005, Pages 216-221

  Fu, D ^a   Vissavajjhala, P ^a   Hemmings Jr , H C ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Anaesthetics, volatile; Pharmacology, neurotransmission effects; Theories of anaesthetic action, molecular

Indexed keywords

CALCIUM ION; HALOTHANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; LIPOSOME; NEUROTRANSMITTER; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; RECOMBINANT PROTEIN; SYNAPTOTAGMIN; SYNAPTOTAGMIN I; UNCLASSIFIED DRUG; ANESTHETIC AGENT; CALCIUM; CALCIUM BINDING PROTEIN; HYBRID PROTEIN; MEMBRANE PROTEIN; NERVE PROTEIN; SYT1 PROTEIN, RAT;

ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG EFFECT; EXOCYTOSIS; INHALATION ANESTHESIA; ISOTOPE LABELING; MOLECULAR INTERACTION; NEUROTRANSMITTER RELEASE; NONHUMAN; PHOSPHOLIPID VESICLE; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; RAT; REGULATORY MECHANISM; SYNAPSE VESICLE; SYNAPTIC TRANSMISSION; ANIMAL; GENETIC ENGINEERING; GENETICS; METABOLISM; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE;

ANESTHETICS; ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; GENETIC ENGINEERING; HALOTHANE; ISOFLURANE; ISOTOPE LABELING; LIPOSOMES; MEMBRANE GLYCOPROTEINS; NERVE TISSUE PROTEINS; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RATS; RECOMBINANT FUSION PROTEINS; SYNAPTOTAGMIN I; SYNAPTOTAGMINS;

EID: 23844460882     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aei163     Document Type: Article

References (30)

1. Franks NP, Lieb WR. Molecular and cellular mechanisms of general anaesthesia. Nature 1994; 367: 607-14
2. Schlame M, Hemmings HC Jr. Inhibition by volatile anesthetics of endogenous glutamate release from synaptosomes by a presynaptic mechanism. Anesthesiology 1995; 82: 1406-16
3. Perouansky M, Baranov D, Salamn M, Yaari Y. Effects of halothane on glutamate receptor-mediated excitatory postsynaptic currents: A patch-clamp study in adult mouse hippocampal slices. Anesthesiology 1995; 83: 109-19
4. MacIver MB, Mikulec AA, Amagasu SM, Monroe FA. Volatile anesthetics depress glutamate transmission via presynaptic actions. Anesthesiology 1996; 85: 823-34
5. Perouansky M, Hemmings HC Jr. Presynaptic actions of general anesthetics. In: Antognini JF, Carstens EE, Raines DE, eds. Neural Mechanisms of Anesthesia. Totowa, NJ: Humana Press, 2003; 345-70
6. Südhof TC. The synaptic vesicle cycle. Annu Rev Neurosci: 2004; 27: 509-47
7. Murthy VN, DeCamilli P. Cell biology of the presynaptic terminal. Annu Rev Neurosci 2003; 26: 701-28
8. Söllner T, Whiteheart SW, Brunner M, et al. SNAP receptors implicated in vesicle targeting and fusion. Nature 2003; 362: 318-24
9. van Swinderen B, Saifee O, Shebester L. Roberson R, Nonet ML, Crowder CM. A neomorphic syntaxin mutation blocks volatile-anesthetic action in Caenorhabditis elegans. Proc Natl Acad Sci USA 1999; 96: 2479-84
10. 2+ sensor for transmitter release at a central synapse. Cell 1994; 79: 717-27
11. Perin MS, Fried VA, Mignery GA, Jahn J, Südhof TC. Phospholipid binding by a synaptic vesicle protein homologous to the regulatory region of protein kinase C. Nature 1990; 345: 260-1
12. Fernández-Chacón R, Königstorfer A, Gerber SH, et al. Synaptotagmin 1 functions as a calcium regulator of release probability. Nature 2001; 410: 41-9
13. 2+ sensor controlling fast synaptic transmission. Neuron 2003; 39: 299-308
14. Kee Y, Scheller RH. Localization of synaptotagmin-binding domains on syntaxin. J Neurosci 1996; 16: 1975-81
15. 2+/phopholipid binding. J Biol Chem 1993; 268: 26386-90
16. Ratnakumari L, Hemmings HC Jr. Inhibition of presynaptic sodium channels by halothane. Anesthesiology 1998; 88: 1043-54
17. 2-homologous domain. J Biol Chem 1994; 269: 5735-41
18. 2+ transients and glutamate release in isolated cerebral synaptosomes. Anesthesiology 1995; 83: 593-603
19. Westphalen RI, Hemmings HC Jr. Selective depression by general anesthetics of glutamate vs. GABA release from isolated nerve terminals. J Pharmacol Exp Ther 2003; 304: 1188-96
20. Taheri S, Halsey MJ, Liu J, Eger El, Koblin DD, Laster MJ. What solvent best represents the site of action of inhaled anesthetics in humans, rats and dogs? Anesth Analg 1991; 72: 627-34
21. Lingamaneni R, Birch ML, Hemmings HC Jr. Widespread inhibition of sodium channel-dependent glutamate release from isolated nerve terminals by isoflurane and propofol. Anesthesiology 2001; 95: 1460-6
22. Hemmings HC Jr, Yan W, Westphalen RI, Ryan TA. The general anesthetic isoflurane depresses synaptic vesicle exocytosis. Mol Pharmacol 2005; 67: 1591-9
23. Wu X-S, Sun J-Y, Evers AS, Crowder M, Wu L-G. Isoflurane inhibits transmitter release and the presynaptic action potential. Anesthesiology 2004; 100: 663-70
24. + channels in isolated rat neurohypophysial nerve terminals. Mol Pharmacol 2003; 64: 1-9
25. OuYang W, Hemmings HC Jr. Depression by isoflurane of the action potential and underlying voltage-gated ion currents in isolated rat neurohypophysial nerve terminals. J Pharmacol Exp Ther 2005; 312: 801-8
26. Hemmings HC Jr, Akabas MH, Goldstein PA, Trudell JR, Orser BA, Harrison NL. Emerging mechanisms of general anesthetic action. Trends Pharmacol Sci 2005; in press
27. Ratnakumari L, Vysotskaya TN, Duch DS, Hemmings HC Jr. Differential effects of anesthetic and nonanesthetic cyclobutanes on neuronal voltage-gated sodium channels. Anesthesiology 2000; 92: 529-41
28. Mikulec AA, Pittson S, Amagasu SM, Monroe FA, Maclver MB. Halothane depresses action potential in hippocampal axons. Brain Res 1998; 796: 231-8
29. + channels. Nat Neurosci 1999; 2: 422-6
30. 2+ currents in hippocampal pyramidal neurons. Anesthesiology 1994; 81: 104-16